{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:22:15Z","timestamp":1788175335052,"version":"build-2803163510"},"reference-count":67,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/or.2014.3597","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T10:42:36Z","timestamp":1415702556000},"page":"250-266","source":"Crossref","is-referenced-by-count":14,"title":["Expression of special AT-rich sequence-binding protein 1 is an independent prognostic factor in cutaneous T-cell lymphoma"],"prefix":"10.3892","volume":"33","author":[{"given":"DARIUSZ","family":"GRZANKA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MACIEJ","family":"GAGAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAGDALENA","family":"IZDEBSKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDRZEJ","family":"MARSZA\u0141EK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,11]]},"reference":[{"key":"key20180107213510_b1-or-33-01-0250","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"key20180107213510_b2-or-33-01-0250","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973\u20132002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"key20180107213510_b3-or-33-01-0250","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"key":"key20180107213510_b4-or-33-01-0250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000018214","article-title":"Cutaneous T cell lymphoma: update of treatment","volume":"199","author":"Zackheim","year":"1999","journal-title":"Dermatology"},{"key":"key20180107213510_b5-or-33-01-0250","first-page":"54","article-title":"Correct answer to the quiz. Check your diagnosis Mycosis fungoides - case report and short overview of the literature","volume":"61","author":"Marsza\u0142ek","year":"2010","journal-title":"Pol J Pathol"},{"key":"key20180107213510_b6-or-33-01-0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.12816\/0006045","article-title":"Review of the treatment of mycosis fungoides and S\u00e9zary syndrome: a stage-based approach","volume":"7","author":"Al Hothali","year":"2013","journal-title":"Int J Health Sci"},{"key":"key20180107213510_b7-or-33-01-0250","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1182\/blood-2010-07-294819","article-title":"Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL\/CD95L transcription","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"key20180107213510_b8-or-33-01-0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-4362.2003.01644.x","article-title":"Treatment of mycosis fungoides\/Sezary syndrome: the University of California, San Francisco (UCSF) approach","volume":"42","author":"Zackheim","year":"2003","journal-title":"Int J Dermatol"},{"key":"key20180107213510_b9-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jnci\/92.13.1042","article-title":"Mitochondrion as a novel target of anticancer chemotherapy","volume":"92","author":"Costantini","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key20180107213510_b10-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"key20180107213510_b11-or-33-01-0250","first-page":"101","article-title":"Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas","volume":"63","author":"Grzanka","year":"2012","journal-title":"Pol J Pathol"},{"key":"key20180107213510_b12-or-33-01-0250","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0092-8674(92)90432-C","article-title":"A tissue-specific MAR\/SAR DNA-binding protein with unusual binding site recognition","volume":"70","author":"Dickinson","year":"1992","journal-title":"Cell"},{"key":"key20180107213510_b13-or-33-01-0250","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gde.2007.08.003","article-title":"The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1","volume":"17","author":"Galande","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107213510_b14-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1128\/MCB.00822-08","article-title":"Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1","volume":"29","author":"Purbey","year":"2009","journal-title":"Mol Cell Biol"},{"key":"key20180107213510_b15-or-33-01-0250","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1128\/MCB.19.7.4918","article-title":"Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation","volume":"19","author":"Liu","year":"1999","journal-title":"Mol Cell Biol"},{"key":"key20180107213510_b16-or-33-01-0250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1101\/gad.14.5.521","article-title":"The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development","volume":"14","author":"Alvarez","year":"2000","journal-title":"Genes Dev"},{"key":"key20180107213510_b17-or-33-01-0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00384-011-1302-9","article-title":"Correlation of SATB1 overexpression with the progression of human rectal cancer","volume":"27","author":"Meng","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"key20180107213510_b18-or-33-01-0250","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s13277-013-0857-1","article-title":"Expression and biological roles of SATB1 in human bladder cancer","volume":"34","author":"Han","year":"2013","journal-title":"Tumour Biol"},{"key":"key20180107213510_b19-or-33-01-0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1479-5876-11-111","article-title":"SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion","volume":"11","author":"Mao","year":"2013","journal-title":"J Transl Med"},{"key":"key20180107213510_b20-or-33-01-0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1479-5876-11-217","article-title":"Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression","volume":"11","author":"Shen","year":"2013","journal-title":"J Transl Med"},{"key":"key20180107213510_b21-or-33-01-0250","doi-asserted-by":"crossref","first-page":"e51786","DOI":"10.1371\/journal.pone.0051786","article-title":"ATM suppresses SATB1-induced malignant progression in breast epithelial cells","volume":"7","author":"Ordinario","year":"2012","journal-title":"PloS One"},{"key":"key20180107213510_b22-or-33-01-0250","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3892\/or.2012.2025","article-title":"Cellular prion protein accelerates colorectal cancer metastasis via the Fyn-SP1-SATB1 axis","volume":"28","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107213510_b23-or-33-01-0250","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3748\/wjg.v19.i15.2331","article-title":"Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer","volume":"19","author":"Fang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20180107213510_b24-or-33-01-0250","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5603\/FHC.2013.0045","article-title":"Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study","volume":"51","author":"Kobierzycki","year":"2013","journal-title":"Folia Histochem Cytobiol"},{"key":"key20180107213510_b25-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3892\/ijmm.2014.1710","article-title":"Involvement of the SATB1\/F-actin complex in chromatin reorganization during active cell death","volume":"33","author":"Grzanka","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20180107213510_b26-or-33-01-0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(80)80385-9","article-title":"Cutaneous T cell lymphoma: mycosis fungoides, S\u00e9zary syndrome, and other variants","volume":"2","author":"Edelson","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"key20180107213510_b27-or-33-01-0250","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0733-8635(18)30863-5","article-title":"Clinical features of cutaneous T-cell lymphoma","volume":"3","author":"Abel","year":"1985","journal-title":"Dermatol Clin"},{"key":"key20180107213510_b28-or-33-01-0250","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"key20180107213510_b29-or-33-01-0250","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"key20180107213510_b30-or-33-01-0250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-109-5-372","article-title":"Histopathologic staging at initial diagnosis of mycosis fungoides and the S\u00e9zary syndrome. Definition of three distinctive prognostic groups","volume":"109","author":"Sausville","year":"1988","journal-title":"Ann Intern Med"},{"key":"key20180107213510_b31-or-33-01-0250","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.135.1.26","article-title":"Clinical characteristics and long-term outcome of patients with generalized patch and\/or plaque (T2) mycosis fungoides","volume":"135","author":"Kim","year":"1999","journal-title":"Arch Dermatol"},{"key":"key20180107213510_b32-or-33-01-0250","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<208::AID-CNCR28>3.0.CO;2-2","article-title":"The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States","volume":"85","author":"Weinstock","year":"1999","journal-title":"Cancer"},{"key":"key20180107213510_b33-or-33-01-0250","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"key20180107213510_b34-or-33-01-0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"key20180107213510_b35-or-33-01-0250","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107213510_b36-or-33-01-0250","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000018131","article-title":"Mycosis fungoides with mucinosis follicularis in childhood","volume":"198","author":"Hess Schmid","year":"1999","journal-title":"Dermatology"},{"key":"key20180107213510_b37-or-33-01-0250","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107213510_b38-or-33-01-0250","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-4362.1991.tb04353.x","article-title":"Mycosis fungoides with oral involvement","volume":"30","author":"Vicente","year":"1991","journal-title":"Int J Dermatol"},{"key":"key20180107213510_b39-or-33-01-0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19940101)73:1<207::AID-CNCR2820730136>3.0.CO;2-C","article-title":"Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin\u2019s Lymphomas for Clinical Usage","volume":"73","author":"Vonderheid","year":"1994","journal-title":"Cancer"},{"key":"key20180107213510_b40-or-33-01-0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008397323199","article-title":"Prognostic factors in S\u00e9zary syndrome: a multivariate analysis of clinical, haematological and immunological features","volume":"9","author":"Bernengo","year":"1998","journal-title":"Ann Oncol"},{"key":"key20180107213510_b41-or-33-01-0250","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key20180107213510_b42-or-33-01-0250","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1523-1747.2000.00830.x","article-title":"Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides","volume":"114","author":"Fraser-Andrews","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key20180107213510_b43-or-33-01-0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archderm.1996.03890250052009","article-title":"Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications","volume":"132","author":"Wasik","year":"1996","journal-title":"Arch Dermatol"},{"key":"key20180107213510_b44-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/Sezary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"key20180107213510_b45-or-33-01-0250","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"key20180107213510_b46-or-33-01-0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-4632.2009.03771.x","article-title":"Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma","volume":"48","author":"Vidulich","year":"2009","journal-title":"Int J Dermatol"},{"key":"key20180107213510_b47-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"key20180107213510_b48-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"},{"key":"key20180107213510_b49-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archderm.1991.01680090075007","article-title":"Prognostic clinicopathologic factors in cutaneous T-cell lymphoma","volume":"127","author":"Mart\u00ed","year":"1991","journal-title":"Arch Dermatol"},{"key":"key20180107213510_b50-or-33-01-0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature06781","article-title":"SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis","volume":"452","author":"Han","year":"2008","journal-title":"Nature"},{"key":"key20180107213510_b51-or-33-01-0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.molcel.2006.03.010","article-title":"Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo","volume":"22","author":"Pavan Kumar","year":"2006","journal-title":"Mol Cell"},{"key":"key20180107213510_b52-or-33-01-0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature01084","article-title":"SATB1 targets chromatin remodelling to regulate genes over long distances","volume":"419","author":"Yasui","year":"2002","journal-title":"Nature"},{"key":"key20180107213510_b53-or-33-01-0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng1146","article-title":"Tissue-specific nuclear architecture and gene expression regulated by SATB1","volume":"34","author":"Cai","year":"2003","journal-title":"Nat Genet"},{"key":"key20180107213510_b54-or-33-01-0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-60761-738-9_20","article-title":"Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator","volume":"647","author":"Notani","year":"2010","journal-title":"Methods Mol Biol"},{"key":"key20180107213510_b55-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2013.05.014","article-title":"The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages","volume":"38","author":"Satoh","year":"2013","journal-title":"Immunity"},{"key":"key20180107213510_b56-or-33-01-0250","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ni.2572","article-title":"Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment","volume":"14","author":"Will","year":"2013","journal-title":"Nat Immunol"},{"key":"key20180107213510_b57-or-33-01-0250","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.devcel.2009.03.006","article-title":"SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells","volume":"16","author":"Agrelo","year":"2009","journal-title":"Dev Cell"},{"key":"key20180107213510_b58-or-33-01-0250","first-page":"534","article-title":"Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer","volume":"29","author":"Zhou","year":"2009","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180107213510_b59-or-33-01-0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1349-7006.2009.01372.x","article-title":"Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci"},{"key":"key20180107213510_b60-or-33-01-0250","first-page":"981","article-title":"SATB1 is an independent prognostic marker for gastric cancer in a Chinese population","volume":"24","author":"Lu","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107213510_b61-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000264777","article-title":"Overexpression of SATB1 in laryngeal squamous cell carcinoma","volume":"72","author":"Zhao","year":"2010","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"key20180107213510_b62-or-33-01-0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdermsci.2011.06.007","article-title":"Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma","volume":"64","author":"Chen","year":"2011","journal-title":"J Dermatol Sci"},{"key":"key20180107213510_b63-or-33-01-0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/cbr.2013.1502","article-title":"Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma","volume":"29","author":"Zhang","year":"2014","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180107213510_b64-or-33-01-0250","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/eji.201141611","article-title":"Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental auto-logous hematopoietic stem transplantation","volume":"41","author":"Bayer","year":"2011","journal-title":"Eur J Immunol"},{"key":"key20180107213510_b65-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"key20180107213510_b66-or-33-01-0250","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/10428190802064917","article-title":"Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma","volume":"49","author":"Capriotti","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20180107213510_b67-or-33-01-0250","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1038\/jid.2009.175","article-title":"FOXP3+CD25\u2212 tumor cells with regulatory function in S\u00e9zary syndrome","volume":"129","author":"Heid","year":"2009","journal-title":"J Invest Dermatol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3597\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T23:41:30Z","timestamp":1650584490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,11]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,11,11]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/or.2014.3597"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3597","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,11]]}}}